[1]
HamaSalih , R.M. et al. 2026. Semaglutide Mitigates Doxorubicin-Induced Hepatic and Renal Damage: Functional, Anti-Inflammatory, and Histopathological Insights. Al-Rafidain Journal of Medical Sciences ( ISSN 2789-3219 ). 10, 1 (Feb. 2026), 163–169. DOI:https://doi.org/10.54133/ajms.v10i1.2626.